Completion of our University of Dundee spin-off new-co Amphista therapeutics’s Series A investment announced today. Great news and congratulations to the whole team for this achievement!
Read more on Twitter
Related links
- University of Dundee Press Release: Funding success for University spinout
- UoD School of Life Sciences PR: https://www.lifesci.dundee.ac.uk/news/2020/apr/7/funding-success-university-spinout
- PR Newswire News: Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer
- PharmiWeb.com PR
- EndPointNews: Another protein degradation biotech emerges, with the promise of a new approach from an old hand
- BioCity News: BIOCITY GLASGOW BASED AMPHISTA THERAPEUTICS RAISES $7.5M SERIES A ROUND
- The Wall Street Journal Pro Venture Capital: Scottish Drugmaker Amphista Therapeutics Gets $7.5 Million Series A
- The Courier: $7.5m funding for Dundee University life sciences spin-out
- Scottish Financial News: Amphista Therapeutics closes £6m funding round
- Labiotech.eu: Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer (Startup of the week)
- P&T Community: Advent Life Sciences Continues Support of Innovation in Life Sciences with the Launch of Two New Cancer Companies
